ArticleScientific reports2026
Combined effects of depression and visual impairment on cardiovascular disease incidence in a Chinese population-based cohort.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Depression and visual impairment (VI) are prevalent in aging populations and known risk factors for cardiovascular disease (CVD). Their combined impact on CVD incidence remains poorly defined. This study investigated the individual and combined effects of depression and VI on incident CVD in a large Chinese cohort. We included 18,633 participants aged ≥ 45 from the China Health and Retirement Longitudinal Study (2011–2018). Participants were categorized into four groups: control, depression only, VI only, and both. Incident CVD was identified during follow-up. Cox regression was used to estimate hazard ratios (HRs). In the fully adjusted model, all three exposure groups had significantly higher CVD risk than the control group. The highest risk was for depression only (HR: 1.60; 95% CI: 1.36–1.89), followed by co-occurring depression and visual impairment (HR: 1.56; 95% CI: 1.40–1.73), and visual impairment only (HR: 1.25; 95% CI: 1.13–1.38). A significant negative multiplicative interaction was observed (HR for interaction: 0.78; 95% CI: 0.65–0.93; p = 0.006). Depression and VI are independently associated with increased CVD risk. Their co-occurrence shows an antagonistic interaction, with combined risk not exceeding that of depression alone. Screening for depressive symptoms in older adults, especially those with VI, may aid CVD prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.